Biotechnology

Biotechnology Industry Market Research Reports

Biotechnology Industry Market Research Reports, Analysis and Trends

 

Publication Single User License (PDF) Price
PD-1 and PD-L1 Inhibitors - Competitive Landscape, Pipeline and Market Analysis, 2016

PD-1 and PD-L1 Inhibitors - Competitive Landscape, Pipeline and Market Analysis, 2016

Date Published: Feb 8 2016
PD-1 and PD-L1 inhibitors - Competitive Landscape, Pipeline and Market Analysis, 2016 gives an insight on the PD-1 and PD-L1 inhibitors, which are amongst the highly growing fields in biopharmaceutical industry. Most of these immunotherapeutic are being used in Oncology. There are 45 drugs in pipeline with approximate 245 active clinical studies. 
 
$2,950.00
RORgamma Modulators 2016: A comparative analysis of the landscape of RORgamma antagonists and agonists

RORgamma Modulators 2016: A comparative analysis of the landscape of RORgamma antagonists and agonists

Date Published: Feb 4 2016
Retinoic acid-related orphan nuclear receptor gamma (RORgamma) is a hot, but „difficult-to-drug“ target. More than 30 companies are active in drug discovery and development. Technology companies with expertise in discovery of drugs targeting nuclear hormone receptors are preferred partners of Big Pharma and Biotech companies if they have identified novel scaffolds of RORgamma antagonists. More than ten such technology-pharma partnerships have been founded and already lead to first successes.
$1,050.00
Enzo Biochem Partnering Deals and Alliances 2010 to 2016

Enzo Biochem Partnering Deals and Alliances 2010 to 2016

Date Published: Feb 2 2016

This report provides all the information you require to better understand Enzo Biochem and its partnering interests and activities since 2010.

Description
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies.

On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.

$1,495.00
Global Myocardial Infarction Partnering 2010 to 2016

Global Myocardial Infarction Partnering 2010 to 2016

Date Published: Feb 2 2016

Provides understanding and access to the myocardial infarction partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.

• Trends in partnering deals
• Top deals by value
• Deals listed by company A-Z, industry sector, stage of development, technology type

$1,495.00
Global Hematology Partnering 2010-2016: Deal trends, players and financials

Global Hematology Partnering 2010-2016: Deal trends, players and financials

Date Published: Feb 2 2016

The Global Hematology Partnering 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the hematology partnering deals and agreements entered into by the worlds leading healthcare companies

Description
Global Hematology Partnering 2010 to 2016 provides the full collection of Hematology disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.

$2,995.00
Nektar Therapeutics Partnering Deals and Alliances 2010 to 2016

Nektar Therapeutics Partnering Deals and Alliances 2010 to 2016

Date Published: Feb 2 2016

This report provides all the information you require to better understand Nektar Therapeutics and its partnering interests and activities since 2010

Description
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies.

On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.

$1,495.00
Global Anemia Partnering 2010 to 2016

Global Anemia Partnering 2010 to 2016

Date Published: Feb 2 2016

Provides understanding and access to the anemia partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.

• Trends in partnering deals
• Top deals by value
• Deals listed by company A-Z, industry sector, stage of development, technology type

$1,495.00
Apotex Partnering Deals and Alliances 2010 to 2016

Apotex Partnering Deals and Alliances 2010 to 2016

Date Published: Feb 2 2016

This report provides all the information you require to better understand Apotex and its partnering interests and activities since 2010

Description
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies.

On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.

$1,495.00
UCB Partnering Deals and Alliances 2010 to 2016

UCB Partnering Deals and Alliances 2010 to 2016

Date Published: Feb 2 2016

This report provides all the information you require to better understand UCB and its partnering interests and activities since 2010.

Description
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies.

On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.

$1,495.00
Global Osteoporosis Partnering 2010 to 2016

Global Osteoporosis Partnering 2010 to 2016

Date Published: Feb 2 2016

Provides understanding and access to the osteoporosis partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.

• Trends in partnering deals
• Top deals by value
• Deals listed by company A-Z, industry sector, stage of development, technology type

$1,495.00
Global Obesity Partnering 2010 to 2016

Global Obesity Partnering 2010 to 2016

Date Published: Feb 2 2016

Provides understanding and access to the obesity partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.

• Trends in partnering deals
• Top deals by value
• Deals listed by company A-Z, industry sector, stage of development, technology type

$1,495.00
Gilead Sciences Partnering Deals and Alliances 2010 to 2016

Gilead Sciences Partnering Deals and Alliances 2010 to 2016

Date Published: Feb 2 2016

This report provides all the information you require to better understand Gilead Sciences and its partnering interests and activities since 2010.

Description
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies.

On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.

$1,495.00
Global Multiple Sclerosis Partnering 2010 to 2016

Global Multiple Sclerosis Partnering 2010 to 2016

Date Published: Feb 2 2016

Provides understanding and access to the multiple sclerosis partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.

• Trends in partnering deals
• Top deals by value
• Deals listed by company A-Z, industry sector, stage of development, technology type

$1,495.00
Global Pediatrics Partnering 2010-2016: Deal trends, players and financials

Global Pediatrics Partnering 2010-2016: Deal trends, players and financials

Date Published: Feb 2 2016

Global Pediatrics Partnering 2010-2016: Deal trends, players and financials provides comprehensive understanding and unprecedented access to the pediatrics partnering deals and agreements entered into by the worlds leading healthcare companies

Description
Global Pediatrics Partnering 2010 to 2016 provides the full collection of Pediatrics disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.

$2,995.00
Purdue Partnering Deals and Alliances 2010 to 2016

Purdue Partnering Deals and Alliances 2010 to 2016

Date Published: Feb 2 2016

This report provides all the information you require to better understand Purdue and its partnering interests and activities since 2010.

Description
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies.

On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.

$1,495.00
Global Sepsis Partnering 2010 to 2016

Global Sepsis Partnering 2010 to 2016

Date Published: Feb 2 2016

Provides understanding and access to the sepsis partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.

• Trends in partnering deals
• Top deals by value
• Deals listed by company A-Z, industry sector, stage of development, technology type

$1,495.00
Biogen Idec Partnering Deals and Alliances 2010 to 2016

Biogen Idec Partnering Deals and Alliances 2010 to 2016

Date Published: Feb 2 2016

This report provides all the information you require to better understand Biogen Idec and its partnering interests and activities since 2010.

Description
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world’s leading life sciences companies.

On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.

$1,495.00
Global Bladder Cancer Partnering 2010 to 2016

Global Bladder Cancer Partnering 2010 to 2016

Date Published: Feb 2 2016

Provides understanding and access to the bladder cancer partnering deals and agreements entered into by the worlds leading healthcare companies

Description
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.

• Trends in partnering deals
• Top deals by value
• Deals listed by company A-Z, industry sector, stage of development, technology type

$1,495.00
Global Melanoma Partnering 2010 to 2016

Global Melanoma Partnering 2010 to 2016

Date Published: Feb 2 2016

Provides understanding and access to the melanoma partnering deals and agreements entered into by the worlds leading healthcare companies .

Description
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.

• Trends in partnering deals
• Top deals by value
• Deals listed by company A-Z, industry sector, stage of development, technology type

$1,495.00
Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016

Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016

Date Published: Feb 2 2016

The Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016 report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering deals and agreements entered into by the worlds leading healthcare companies

Description
The Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016 report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering agreements entered into by the worlds leading healthcare companies.

$2,995.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data